Sign in

    Ernest Watts

    Research Analyst at Watts Associates

    No publicly available sources, including LinkedIn, business directories, research analyst rankings, or professional licensing records, provide evidence of an Ernest Watts working as an analyst or in any other listed capacity at Watts Associates. No performance metrics, company coverage lists, career timeline, or credentials could be verified for an individual with this name and role. Based on all available search data, there is no substantiated public professional profile for Ernest Watts at Watts Associates.

    Ernest Watts's questions to BIOSTEM TECHNOLOGIES (BSEM) leadership

    Ernest Watts's questions to BIOSTEM TECHNOLOGIES (BSEM) leadership • Q3 2024

    Question

    Ernest Watts from Watts Associates asked for clarification on 'buildup costs' that precede revenues, requesting specific figures for these costs in Q2 and Q3.

    Answer

    Jason Matuszewski, Founder and CEO, clarified that the primary cost is 'bona fide service fees' paid to Venture Medical, which correlate directly with revenue. CFO Michael Fortunato specified these fees, part of sales and marketing, were $65.1 million in Q3 and approximately in the 'mid-50s' million range in Q2, reiterating that they scale with revenue.

    Ask Fintool Equity Research AI